NCT00273507终止3 期
Neoadjuvant Chemotherapy in Resectable NSCLC Stages IB, IIA, IIB, and IIIA/T3 But Not IIIA/N2
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 入组人数
- 270
- 试验地点
- 2
- 主要终点
- Survival
研究概览
简要总结
Randomised trial of chemotherapy or not before surgery in early resectable stages of NSCLC (IB, IIA, IIB, and IIIA/N2).
详细描述
Randomisation between 3 courses of neoadjuvant Carboplatin plus Paclitaxel or no chemotherapy before surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Stages IB, IIA, IIB, IIIA/T3
- •Lung function test allowing surgery
- •Age 18-75 years
排除标准
- •Poor lung function
- •Performance status 3-4
- •Mediastinal lymph node involvement
结局指标
主要结局
Survival
次要结局
- Time to progression
- Complete resection rate
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLCNon-Small Cell Lung CancerNCT00191126Eli Lilly and Company263
进行中（未招募）
不适用
Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)Non-Small Cell Lung CancerNCT01817192Razor Genomics420
Unknown
3 期
Neoadjuvant Chemotherapy + Surgery Versus Surgery in FIGO IB2 and IIA2 Cervical CancerPFSQuality of LifeOSNCT02629718Sun Yat-sen University700
Unknown
2 期
Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal CancerEsophageal NeoplasmsConcurrent ChemoradiotherapySquamous Cell CarcinomaNCT03579004Mona Frolova48
招募中
2 期
To evaluate Neoadjuvant chemotherapy in treatment of unresectable cervical cancer patientsIRCT20210808052110N1Shiraz University of Medical Sciences74